Receptive Music Interventions During Intradermal Testing in Children

Hilal Gungor120 enrolled

Overview

The study summary and design were to assess procedural anxiety and stress in parents and pain perception in children during intradermal testing. Music medicine was incorporated into the study design as a nonpharmacological intervention. Two distinct auditory modalities were used: solfeggio frequencies-174 Hz, 285 Hz, 396 Hz, and 528 Hz-which have been suggested to interact with the human energy field through resonance-based mechanisms, and Turkish classical musical modes (makams), such as Rast, Hicaz, Uşşak, Neva, and Saba, which are modal systems that include microtonal intervals and follow specific melodic progressions that are often associated with different emotional and spiritual effects as well as sensory and emotional regulation potential.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

120

Conditions

Music Therapy Anxiety Pain Management Skin Tests

Interventions

Receptive Music Therapy - Solfeggio FrequenciesBEHAVIORAL

Music featuring Solfeggio frequencies (174 Hz, 285 Hz, 396 Hz, 528 Hz) is played through standardized speakers in a sound-isolated room during IDT. Duration includes five minutes before and throughout the procedure

Receptive Music Therapy - Traditional Turkish MusicBEHAVIORAL

Selected Turkish Classical Music pieces (makams: Rast, Hicaz, Uşşak, Neva, Saba) are played via speakers in a sound-isolated room during IDT. Music begins five minutes prior and continues during the procedure.

Eligibility

Sex: ALLMin age: 2 YearsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Children aged between 2 and 17 years 2. Referred to the Pediatric Allergy Clinic for evaluation of suspected drug hypersensitivity reactions 3. Accompanied by a parent or legal guardian willing to participate 4. Written informed consent obtained from parents or legal guardians Exclusion Criteria: 1. Known neurological, psychiatric, or developmental disorders in the child 2. Use of sedatives or analgesic medications within 24 hours prior to testing 3. Hearing impairment or auditory processing disorders in the child4.Non-consent or withdrawal of consent by parent or guardian 4. Inability of the parent to complete anxiety assessments (e.g., due to language or cognitive barriers)

Outcomes

Primary Outcomes

Change in Parental State Anxiety Levels

Change in parental state anxiety will be assessed using the State-Trait Anxiety Inventory - State Subscale (STAI-S). The STAI-S is a validated psychological inventory that measures current levels of anxiety. It consists of 20 items, each rated on a 4-point Likert scale, with total scores ranging from 20 to 80. Higher scores indicate greater levels of anxiety. STAI-S scores will be collected immediately before and immediately after the intradermal testing (IDT) procedure. The change in anxiety levels will be calculated as the difference between post-procedure and pre-procedure scores (ΔSTAI-S), and will be used to evaluate the effect of the intervention.

Time frame: within 5 minutes before and post procedure

Pain Levels in Pediatric Patients During Intradermal Testing

Pain scores will be evaluated immediately after the intradermal testing (IDT) procedure. For children under 5 years of age, pain will be assessed using the Children's Hospital of Eastern Ontario Pain Scale (CHEOPS). This is a behavioral pain assessment tool with scores ranging from 4 to 13, where higher scores indicate greater pain. For children aged 5 years and older, pain will be assessed using the Wong-Baker FACES Pain Rating Scale. This self-report scale ranges from 0 to 10, where higher scores indicate greater pain.

Time frame: within 2 minutes post-procedure